Experts disagree on whether the fourth wave is coming
The Covid-19 vaccine may be accelerating in the United States, but the Biden administration has intervened in a troubled factory that destroyed millions of doses of the vaccine. Coupled with the continued threat of dangerous variants of the coronavirus, this indicates The way to fight against it will likely experience many unforeseen twists and turns.
According to data from the US Centers for Disease Control and Prevention, Saturday was the first time that the country reported more than 4 million doses of Covid-19 per day, bringing the number to an average of over 3 million for the first time.
On the same day, due to the closure of a contracted factory in Baltimore, accidents continued to occur, destroying 15 million doses of Johnson & Johnson’s vaccine. Senior federal health officials said that the Biden government appointed Johnson & Johnson to be responsible for the facility and took steps to prevent the facility from producing another vaccine, which was developed by AstraZeneca.
In this move, Biden actively lobbied to produce enough vaccine doses to cover all American adults by the end of May. According to two senior federal health officials, it will leave the Baltimore plant that specializes in manufacturing Johnson & Johnson’s single-dose vaccines in order to avoid future chaos. Johnson & Johnson confirmed this change and stated that it was “fully responsible” for the vaccine produced by the manufacturer Emergent BioSolutions, which accidentally mixed the components of two different vaccines.
Federal officials worry that this confusion has eroded public trust in vaccines. At the beginning of March, the country averaged over 2 million doses per day, while in mid-January there were about 800,000 doses per day. As more and more states expand qualifications and increase production, nearly one-third of the U.S. population has received at least one dose of the Covid-19 vaccine.
Although the number of new virus cases, deaths and hospitalizations is well below the peak in January, the average number of new cases reported in the past two weeks has increased by 19%. As the mutation spreads, cases have increased significantly in many states, especially in the Midwest and Northeast.